Literature DB >> 15216451

Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.

N B Tütüncü1, T Erbaş.   

Abstract

The purpose of the study was to determine the factors associated with bone metabolism in acromegalic patients. Thirty three patients with acromegaly who had been followed on a regular basis in the endocrinology clinic were enrolled for the study. Among the factors acting upon bone metabolism, age, gender, body mass index (BMI), duration and activity of the disease, length of remission, treatment modalities and functional status of the pituitary were evaluated. Their influences on the determinants of bone remodelling and bone mineral density (BMD) were tried to be elucidated. The median age of the 33 acromegalics (19 females, 14 males) was 39.73 +/- 10.1 years. Twenty-three patients (9 males and 14 females) were eugonadal. Ten patients had been diagnosed with history of at least one year of untreated hypogonadism (5 males and 5 females; for 1 - 10 years). The BMD values of the lumbar vertebrae, the femur and the radius were correlated with each other. Patients were grouped according to their T-scores as decreased, normal, and increased BMD. Groups were similar with regard to age, BMI, gender, duration of disease, and remission, GH, IGF-1, IGFBP-3 levels, markers of bone turnover. Presence of hypogonadism and duration of hypogonadism revealed statistically significant difference among the 3 groups (p = 0.005 and p = 0.035, respectively). Hypogonadal acromegalic patients had decreased BMD compared to eugonadal acromegalics and healthy population while the eugonadal female acromegalic patients revealed increased BMD of lumbar vertebrae, femur, and distal radius compared to the sex-matched healthy population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15216451     DOI: 10.1055/s-2004-820913

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients.

Authors:  Yesim Ozdemir; H Gencay Keceli; Nafiye Helvaci; Tomris Erbas; Rahime M Nohutcu
Journal:  Endocrine       Date:  2019-09-02       Impact factor: 3.633

Review 2.  Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.

Authors:  Cláudia Ribeiro de Moura; Sara Campos Lopes; Ana Margarida Monteiro
Journal:  Pituitary       Date:  2022-07-22       Impact factor: 3.599

3.  Alterations in body composition in acromegaly.

Authors:  Laurence Katznelson
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 4.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

5.  Trabecular bone score as a skeletal fragility index in acromegaly patients.

Authors:  A R Hong; J H Kim; S W Kim; S Y Kim; C S Shin
Journal:  Osteoporos Int       Date:  2015-10-07       Impact factor: 4.507

6.  Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study.

Authors:  Madalina Cristina Sorohan; Roxana Dusceac; Bogdan Marian Sorohan; Andra Caragheorgheopol; Catalina Poiana
Journal:  Arch Osteoporos       Date:  2021-09-16       Impact factor: 2.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.